The latest closing stock price for Dianthus Therapeutics as of November 20, 2024 is 20.77.
An investor who bought $1,000 worth of Dianthus Therapeutics stock at the IPO in 2018 would have $-911 today, roughly -1 times their original investment - a -33.13% compound annual growth rate over 6 years.
The all-time high Dianthus Therapeutics stock closing price was 315.20 on March 25, 2019.
The Dianthus Therapeutics 52-week high stock price is 33.77, which is 62.6% above the current share price.
The Dianthus Therapeutics 52-week low stock price is 6.58, which is 68.3% below the current share price.
The average Dianthus Therapeutics stock price for the last 52 weeks is 23.49.
An investor who bought $1,000 worth of Dianthus Therapeutics stock at the IPO in 2018 would have $-911 today, roughly -1 times their original investment - a -33.13% compound annual growth rate over 6 years.
The all-time high Dianthus Therapeutics stock closing price was 315.20 on March 25, 2019.
The Dianthus Therapeutics 52-week high stock price is 33.77, which is 62.6% above the current share price.
The Dianthus Therapeutics 52-week low stock price is 6.58, which is 68.3% below the current share price.
The average Dianthus Therapeutics stock price for the last 52 weeks is 23.49.